Concepedia

R. Borson

RB

Statistics

Publications

4

Citations

888

H-Index

4

Active since

1995

Affiliations

Texas Oncology(Current)

Sarah Cannon

R. Borson is an author at Texas Oncology specializing in oncology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1995–2010

4

Publications

4

Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy

Howard A. Burris, Hope S. Rugo, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2010 · 758 citations · Full text

A phase II study of trastuzumab-DM1 (T-DM1), a HER2 antibody-drug conjugate (ADC), in patients (pts) with HER2+ metastatic breast cancer (MBC): Final results

C. L. Vogel, Howard A. Burris, Steven Limentani et al. · Journal of Clinical Oncology · 2009 · 63 citations

, , +20

Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: A summary of case reports

Lewis Cohen, Nancy B. McWilliams, Ronnie W. Neuberg et al. · American Journal of Hematology · 1995 · 40 citations

A phase II study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer.

S. Vukelja, Hope S. Rugo, C Vogel et al. · Cancer Research · 2009 · 27 citations

, , +20

1–4 of 4